| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |